BlackRock Fund Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.44M Buy
443,866
+59,222
+15% +$443K ﹤0.01% 3045
2016
Q3
$2.93M Buy
384,644
+22,901
+6% +$129K ﹤0.01% 3076
2016
Q2
$1.82M Buy
361,743
+6,891
+2% +$36.9K ﹤0.01% 3205
2016
Q1
$1.92M Sell
354,852
-2,467
-0.7% -$14.6K ﹤0.01% 3089
2015
Q4
$2.57M Buy
357,319
+9,969
+3% +$67.1K ﹤0.01% 3088
2015
Q3
$1.63M Sell
347,350
-4,085
-1% -$38.9K ﹤0.01% 3155
2015
Q2
$3.92M Buy
+351,435
New +$3.46M ﹤0.01% 3023

Other funds holding VCYT

BlackRock Fund Advisors's VCYT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Veracyte (VCYT) stake by 15% in Q4 2016, buying an estimated $443K and bringing the position to 443,866 shares worth $3.44M. The position accounts for ﹤0.01% of the portfolio, ranked #3045.

BlackRock Fund Advisors first reported a position in VCYT in Q2 2015 and has held it in 7 quarters since. The position peaked at $3.92M in Q2 2015. 74 funds tracked by Wall St. Rank hold VCYT as of Q4 2016.

  • BlackRock Fund Advisors held 443,866 shares of Veracyte worth $3.44M as of Q4 2016.
  • BlackRock Fund Advisors bought 59,222 Veracyte shares in Q4 2016, an estimated $443K.
  • Veracyte made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3045 holding.
  • BlackRock Fund Advisors first reported a position in Veracyte in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Fund Advisors's Veracyte position peaked at $3.92M in Q2 2015.
  • 74 funds tracked by Wall St. Rank held Veracyte as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.